This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: China University of Geosciences (Wuhan). Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Juan Liao - Innovator in Diagnostic and Therapeutic Agents
Introduction
Juan Liao is a notable inventor based in Wuhan, China. He has made significant contributions to the field of diagnostic and therapeutic agents, particularly through his innovative use of kaolinite composites. His work has the potential to impact medical treatments and diagnostics significantly.
Latest Patents
Juan Liao holds a patent for a "Kaolinite composite diagnostic and therapeutic agent and preparation method and use thereof." This invention utilizes modified kaolinite as a carrier, which is loaded with carbon nitride quantum dots and doxorubicin. The preparation method involves several steps, including the intercalation, exfoliation, and immersion wet etching of pharmaceutical-grade kaolinite. The process continues with ultrasonication, drying, and grinding to create a kaolinite composite containing carbon nitride quantum dots. Finally, doxorubicin is dissolved and added to the composite, resulting in a diagnostic and therapeutic agent.
Career Highlights
Juan Liao has worked at prominent institutions, including the China University of Geosciences (Wuhan) and ZTE Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions in the medical field.
Collaborations
Juan has collaborated with notable colleagues, including Huaming Yang and Jianwei Tian. Their combined efforts have further advanced the research and development of diagnostic and therapeutic technologies.
Conclusion
Juan Liao's innovative work in the field of diagnostic and therapeutic agents showcases his commitment to advancing medical science. His patent on kaolinite composites represents a significant step forward in the development of effective treatment methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile